in | 6M22 | 6M21 | |||
Consolidated statements of operations (CHF million) | |||||
Interest and dividend income |
|
|
|||
Interest expense |
( |
( |
|||
Net interest income |
|
|
|||
Commissions and fees |
|
|
|||
Trading revenues |
( |
|
|||
Other revenues |
|
|
|||
Net revenues |
|
|
|||
Provision for credit losses |
( |
|
|||
Compensation and benefits |
|
|
|||
General and administrative expenses |
|
|
|||
Commission expenses |
|
|
|||
Goodwill impairment |
|
|
|||
Restructuring expenses |
|
|
|||
Total other operating expenses |
|
|
|||
Total operating expenses |
|
|
|||
Income/(loss) before taxes |
( |
|
|||
Income tax expense |
|
|
|||
Net income/(loss) |
( |
|
|||
Loss attributable to noncontrolling interests |
( |
( |
|||
Net income/(loss) attributable to shareholders |
( |
|
in | 6M22 | 6M21 | |||
Comprehensive income/(loss) (CHF million) | |||||
Net income/(loss) |
( |
|
|||
Gains/(losses) on cash flow hedges |
( |
( |
|||
Foreign currency translation |
|
|
|||
Unrealized gains/(losses) on securities |
( |
|
|||
Actuarial gains/(losses) |
|
( |
|||
Gains/(losses) on liabilities related to credit risk |
|
|
|||
Other comprehensive income, net of tax |
|
|
|||
Comprehensive income |
|
|
|||
Comprehensive income/(loss) attributable to noncontrolling interests |
|
( |
|||
Comprehensive income attributable to shareholders |
|
|
end of | 6M22 | 2021 | |||
Assets (CHF million) | |||||
Cash and due from banks |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Interest-bearing deposits with banks |
|
|
|||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|||
of which reported at fair value |
|
|
|||
Securities received as collateral, at fair value |
|
|
|||
of which encumbered |
|
|
|||
Trading assets, at fair value |
|
|
|||
of which encumbered |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Investment securities |
|
|
|||
of which reported at fair value |
|
|
|||
of which encumbered |
|
|
|||
Other investments |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Net loans |
|
|
|||
of which reported at fair value |
|
|
|||
of which encumbered |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
allowance for credit losses |
( |
( |
|||
Goodwill |
|
|
|||
Other intangible assets |
|
|
|||
of which reported at fair value |
|
|
|||
Brokerage receivables |
|
|
|||
allowance for credit losses |
( |
( |
|||
Other assets |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
of which loans held-for-sale (amortized cost base) |
|
|
|||
allowance for credit losses - other assets held at amortized cost |
( |
( |
|||
Total assets |
|
|
end of | 6M22 | 2021 | |||
Liabilities and equity (CHF million) | |||||
Due to banks |
|
|
|||
of which reported at fair value |
|
|
|||
Customer deposits |
|
|
|||
of which reported at fair value |
|
|
|||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|||
of which reported at fair value |
|
|
|||
Obligation to return securities received as collateral, at fair value |
|
|
|||
Trading liabilities, at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Short-term borrowings |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Long-term debt |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Brokerage payables |
|
|
|||
Other liabilities |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Total liabilities |
|
|
|||
Common shares |
|
|
|||
Additional paid-in capital |
|
|
|||
Retained earnings |
|
|
|||
Accumulated other comprehensive income/(loss) |
( |
( |
|||
Total shareholders' equity |
|
|
|||
Noncontrolling interests |
|
|
|||
Total equity |
|
|
|||
Total liabilities and equity |
|
|
end of | 6M22 | 2021 | |||
Additional share information | |||||
Par value (CHF) |
|
|
|||
Issued shares |
|
|
|||
Shares outstanding |
|
|
|||
|
Attributable to shareholders | |||||||||||||||||
Common shares |
Additional paid-in capital |
Retained earnings |
Treasury shares, at cost |
1 |
AOCI |
Total share- holders' equity |
Non- controlling interests |
Total equity |
|||||||||
6M22 (CHF million) | |||||||||||||||||
Balance at beginning of period |
|
|
|
|
( |
|
|
|
|||||||||
Purchase of subsidiary shares from non- controlling interests, not changing ownership 2, 3 | – | – | – | – | – | – |
( |
( |
|||||||||
Sale of subsidiary shares to noncontrolling interests, not changing ownership 3 | – | – | – | – | – | – |
|
|
|||||||||
Net income/(loss) | – | – |
( |
– | – |
( |
( |
( |
|||||||||
Total other comprehensive income/(loss), net of tax | – | – | – | – |
|
|
|
|
|||||||||
Share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends on share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends paid | – |
( |
– | – | – |
( |
( |
( |
|||||||||
Changes in scope of consolidation, net | – | – | – | – | – | – |
( |
( |
|||||||||
Balance at end of period |
|
|
|
|
( |
|
|
|
|||||||||
6M21 (CHF million) | |||||||||||||||||
Balance at beginning of period |
|
|
|
|
( |
|
|
|
|||||||||
Purchase of subsidiary shares from non- controlling interests, not changing ownership | – | – | – | – | – | – |
( |
( |
|||||||||
Sale of subsidiary shares to noncontrolling interests, not changing ownership | – | – | – | – | – | – |
|
|
|||||||||
Net income/(loss) | – | – |
|
– | – |
|
( |
|
|||||||||
Total other comprehensive income/(loss), net of tax | – | – | – | – |
|
|
|
|
|||||||||
Share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends on share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends paid | – | – |
( |
– | – |
( |
( |
( |
|||||||||
Changes in scope of consolidation, net | – | – | – | – | – | – |
|
|
|||||||||
Other | – |
|
– | – | – |
|
( |
|
|||||||||
Balance at end of period |
|
|
|
|
( |
|
|
|
|||||||||
1
|
|||||||||||||||||
2
|
|||||||||||||||||
3
|
in | 6M22 | 6M21 | |||
Operating activities (CHF million) | |||||
Net income/(loss) |
( |
|
|||
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities (CHF million) | |||||
Impairment, depreciation and amortization |
|
|
|||
Provision for credit losses |
( |
|
|||
Deferred tax provision/(benefit) |
( |
( |
|||
Share-based compensation |
|
|
|||
Valuation adjustments relating to long-term debt |
( |
|
|||
Share of net income/(loss) from equity method investments |
( |
( |
|||
Trading assets and liabilities, net |
|
|
|||
(Increase)/decrease in other assets |
( |
( |
|||
Increase/(decrease) in other liabilities |
( |
( |
|||
Other, net |
( |
( |
|||
Total adjustments |
( |
|
|||
Net cash provided by/(used in) operating activities |
( |
|
|||
Investing activities (CHF million) | |||||
(Increase)/decrease in interest-bearing deposits with banks |
|
|
|||
(Increase)/decrease in central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
( |
( |
|||
Purchase of investment securities |
( |
( |
|||
Proceeds from sale of investment securities |
|
|
|||
Maturities of investment securities |
|
|
|||
Investments in subsidiaries and other investments |
( |
( |
|||
Proceeds from sale of other investments |
|
|
|||
(Increase)/decrease in loans |
|
( |
|||
Proceeds from sales of loans |
|
|
|||
Capital expenditures for premises and equipment and other intangible assets |
( |
( |
|||
Proceeds from sale of premises and equipment and other intangible assets |
|
|
|||
Other, net |
|
|
|||
Net cash provided by/(used in) investing activities |
|
( |
in | 6M22 | 6M21 | |||
Financing activities (CHF million) | |||||
Increase/(decrease) in due to banks and customer deposits |
( |
|
|||
Increase/(decrease) in short-term borrowings |
|
|
|||
Increase/(decrease) in central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
( |
( |
|||
Issuances of long-term debt |
|
|
|||
Repayments of long-term debt |
( |
( |
|||
Dividends paid |
( |
( |
|||
Other, net |
( |
|
|||
Net cash provided by/(used in) financing activities |
( |
( |
|||
Effect of exchange rate changes on cash and due from banks (CHF million) | |||||
Effect of exchange rate changes on cash and due from banks |
|
|
|||
Net increase/(decrease) in cash and due from banks (CHF million) | |||||
Net increase/(decrease) in cash and due from banks |
( |
|
|||
Cash and due from banks at beginning of period 1 |
|
|
|||
Cash and due from banks at end of period 1 |
|
|
|||
1
|
in | 6M22 | 6M21 | |||
Cash paid for income taxes and interest (CHF million) | |||||
Cash paid for income taxes |
|
|
|||
Cash paid for interest |
|
|
in | 6M22 | 6M21 | |||
Net revenues (CHF million) | |||||
Wealth Management |
|
|
|||
Investment Bank |
|
|
|||
Swiss Bank |
|
|
|||
Asset Management |
|
|
|||
Adjustments 1 |
( |
|
|||
Net revenues |
|
|
|||
Income/(loss) before taxes (CHF million) | |||||
Wealth Management |
( |
|
|||
Investment Bank |
( |
( |
|||
Swiss Bank |
|
|
|||
Asset Management |
|
|
|||
Adjustments 1 |
( |
( |
|||
Income/(loss) before taxes |
( |
|
|||
1
Adjustments represent certain consolidating entries and balances, including those relating to items that are managed but are not legally owned by the Bank and vice versa, and certain revenues and expenses that were not allocated to the segments, including such items relating to the Asset Resolution Unit.
|
end of | 6M22 | 2021 | |||
Total assets (CHF million) | |||||
Wealth Management |
|
|
|||
Investment Bank |
|
|
|||
Swiss Bank |
|
|
|||
Asset Management |
|
|
|||
Adjustments 1 |
|
|
|||
Total assets |
|
|
|||
1
Adjustments represent certain consolidating entries and balances, including those relating to items that are managed but are not legally owned by the Bank and vice versa, and certain revenues and expenses that were not allocated to the segments, including such items relating to the Asset Resolution Unit.
|
in | 6M22 | 6M21 | |||
Net interest income (CHF million) | |||||
Loans |
|
|
|||
Investment securities |
( |
|
|||
Trading assets, net of trading liabilities 1 |
|
|
|||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|||
Other |
|
|
|||
Interest and dividend income |
|
|
|||
Deposits |
( |
( |
|||
Short-term borrowings |
( |
|
|||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
( |
( |
|||
Long-term debt |
( |
( |
|||
Other |
( |
( |
|||
Interest expense |
( |
( |
|||
Net interest income |
|
|
|||
1
Interest and dividend income is presented on a net basis to align with the presentation of trading revenues for trading assets and liabilities.
|
in | 6M22 | 6M21 | |||
Commissions and fees (CHF million) | |||||
Lending business |
|
|
|||
Investment and portfolio management |
|
|
|||
Other securities business |
|
|
|||
Fiduciary business |
|
|
|||
Underwriting |
|
|
|||
Brokerage |
|
|
|||
Underwriting and brokerage |
|
|
|||
Other services |
|
|
|||
Commissions and fees |
|
|
in | 6M22 | 6M21 | |||
Trading revenues (CHF million) | |||||
Interest rate products |
( |
|
|||
Foreign exchange products |
|
|
|||
Equity/index-related products |
|
|
|||
Credit products |
|
( |
|||
Commodity and energy products |
|
|
|||
Other products |
( |
( |
|||
Trading revenues |
( |
|
|||
Represents revenues on a product basis which are not representative of business results within segments, as segment results utilize financial instruments across various product types.
|
in | 6M22 | 6M21 | |||
Other revenues (CHF million) | |||||
Loans held-for-sale |
( |
( |
|||
Long-lived assets held-for-sale |
|
|
|||
Equity method investments |
|
|
|||
Other investments |
( |
|
|||
Other |
|
|
|||
Other revenues |
|
|
in | 6M22 | 6M21 | |||
Provision for credit losses (CHF million) | |||||
Loans held at amortized cost |
|
( |
|||
Other financial assets held at amortized cost 1 |
( |
|
|||
Off-balance sheet credit exposures |
( |
( |
|||
Provision for credit losses |
( |
|
|||
1
Primarily reflects a provision/(release of provision) for credit losses of CHF (
|
in | 6M22 | 6M21 | |||
Compensation and benefits (CHF million) | |||||
Salaries and variable compensation |
|
|
|||
Social security |
|
|
|||
Other 1 |
|
|
|||
Compensation and benefits |
|
|
|||
1
Includes pension-related expenses of CHF
|
in | 6M22 | 6M21 | |||
General and administrative expenses (CHF million) | |||||
Occupancy expenses |
|
|
|||
IT, machinery and equipment |
|
|
|||
Provisions and losses |
|
|
|||
Travel and entertainment |
|
|
|||
Professional services |
|
|
|||
Communication and market data services |
|
|
|||
Amortization and impairment of other intangible assets |
|
|
|||
Other 1 |
|
|
|||
General and administrative expenses |
|
|
|||
1
Includes pension-related expenses/(credits) of CHF
|
in | 6M22 | 6M21 | |||
Restructuring expenses by type (CHF million) | |||||
Compensation and benefits-related expenses |
|
|
|||
of which severance expenses |
|
|
|||
of which accelerated deferred compensation |
|
|
|||
General and administrative-related expenses |
|
|
|||
of which pension expenses |
|
|
|||
Total restructuring expenses |
|
|
6M22 | 6M21 | ||||||||||||
in |
Compen- sation and benefits |
General and administrative expenses |
Total |
Compen- sation and benefits |
General and administrative expenses |
Total |
|||||||
Restructuring liabilities (CHF million) | |||||||||||||
Balance at beginning of period |
|
|
|
|
|
|
|||||||
Net additional charges 1 |
|
|
|
|
|
|
|||||||
Utilization |
( |
( |
( |
( |
( |
( |
|||||||
Balance at end of period |
|
|
|
|
|
|
|||||||
1
The following items for which expense accretion was accelerated in 6M22 and 6M21 due to the restructuring of the Bank are not included in the restructuring provision: unsettled share-based compensation of CHF
|
in | 6M22 | 6M21 | |||
Contracts with customers (CHF million) | |||||
Investment and portfolio management |
|
|
|||
Other securities business |
|
|
|||
Underwriting |
|
|
|||
Brokerage |
|
|
|||
Other services |
|
|
|||
Total revenues from contracts with customers |
|
|
end of | 2Q22 | 1Q22 | 4Q21 | ||||
Contract balances (CHF million) | |||||||
Contract receivables |
|
|
|
||||
Contract liabilities |
|
|
|
||||
Revenue recognized in the reporting period included in the contract liabilities balance at the beginning of period |
|
|
|
end of | 6M22 | 2021 | |||
Trading assets (CHF million) | |||||
Debt securities |
|
|
|||
Equity securities |
|
|
|||
Derivative instruments 1 |
|
|
|||
Other |
|
|
|||
Trading assets |
|
|
|||
Trading liabilities (CHF million) | |||||
Short positions |
|
|
|||
Derivative instruments 1 |
|
|
|||
Trading liabilities |
|
|
|||
1
Amounts shown after counterparty and cash collateral netting.
|
end of | 6M22 | 2021 | |||
Cash collateral on derivative instruments – netted (CHF million) 1 | |||||
Cash collateral paid |
|
|
|||
Cash collateral received |
|
|
|||
Cash collateral on derivative instruments – not netted (CHF million) 2 | |||||
Cash collateral paid |
|
|
|||
Cash collateral received |
|
|
|||
1
Recorded as cash collateral netting on derivative instruments in Note 23 – Offsetting of financial assets and financial liabilities.
|
|||||
2
Recorded as cash collateral on derivative instruments in Note 20 – Other assets and other liabilities.
|
end of | 6M22 | 2021 | |||
Investment securities (CHF million) | |||||
Debt securities available-for-sale |
|
|
|||
Total investment securities |
|
|
6M22 | 2021 | ||||||||||||||||
end of |
Amortized cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
Amortized cost |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
|||||||||
Investment securities by type (CHF million) | |||||||||||||||||
Corporate debt securities |
|
|
|
|
|
|
|
|
|||||||||
Debt securities available-for-sale |
|
|
|
|
|
|
|
|
Less than 12 months | 12 months or more | Total | |||||||||||
end of |
Fair value |
Gross unrealized losses |
Fair value |
Gross unrealized losses |
Fair value |
Gross unrealized losses |
|||||||
6M22 (CHF million) | |||||||||||||
Corporate debt securities |
|
|
|
|
|
|
|||||||
Debt securities available-for-sale |
|
|
|
|
|
|
|||||||
2021 (CHF million) | |||||||||||||
Corporate debt securities |
|
|
|
|
|
|
|||||||
Debt securities available-for-sale |
|
|
|
|
|
|
in | 6M22 | 6M21 | |||
Sales of debt securities available-for-sale (CHF million) | |||||
Proceeds from sales |
|
|
|||
Realized losses |
( |
|
end of 6M22 |
Amortized cost |
Fair value |
Average yield (in %) |
||||
Due within 1 year |
|
|
|
||||
Due from 1 to 5 years |
|
|
( |
||||
Due from 5 to 10 years |
|
|
|
||||
Debt securities available-for-sale |
|
|
|
end of | 6M22 | 2021 | |||
Other investments (CHF million) | |||||
Equity method investments |
|
|
|||
Equity securities (without a readily determinable fair value) 1 |
|
|
|||
of which at net asset value |
|
|
|||
of which at measurement alternative |
|
|
|||
of which at fair value |
|
|
|||
of which at cost less impairment |
|
|
|||
Real estate held-for-investment 2 |
|
|
|||
Life finance instruments 3 |
|
|
|||
Total other investments |
|
|
|||
1
Includes private equity, hedge funds and restricted stock investments as well as certain investments in non-marketable mutual funds for which the Bank has neither significant influence nor control over the investee.
|
|||||
2
As of the end of 6M22 and 2021, real estate held for investment included foreclosed or repossessed real estate of CHF
|
|||||
3
Includes single premium immediate annuity contracts.
|
in / end of | 6M22 | Cumulative | 6M21 | ||||
Impairments and adjustments (CHF million) | |||||||
Impairments and downward adjustments |
( |
( |
( |
||||
Upward adjustments |
|
|
|
end of | 6M22 | 2021 | |||
Loans (CHF million) | |||||
Mortgages |
|
|
|||
Loans collateralized by securities |
|
|
|||
Consumer finance |
|
|
|||
Consumer |
|
|
|||
Real estate |
|
|
|||
Commercial and industrial loans |
|
|
|||
Financial institutions |
|
|
|||
Governments and public institutions |
|
|
|||
Corporate & institutional |
|
|
|||
Gross loans |
|
|
|||
of which held at amortized cost |
|
|
|||
of which held at fair value |
|
|
|||
Net (unearned income)/deferred expenses |
( |
( |
|||
Allowance for credit losses |
( |
( |
|||
Net loans |
|
|
|||
Gross loans by location | |||||
Switzerland |
|
|
|||
Foreign |
|
|
|||
Gross loans |
|
|
|||
Impaired loans | |||||
Non-performing loans |
|
|
|||
Non-interest-earning loans |
|
|
|||
Non-accrual loans |
|
|
|||
Restructured loans |
|
|
|||
Potential problem loans |
|
|
|||
Other impaired loans |
|
|
|||
Gross impaired loans 1 |
|
|
|||
1
As of the end of 6M22 and 2021, CHF
|
6M22 | 2021 | ||||||||||||
end of |
Amortized cost basis |
1 |
Allowance for credit losses |
Net carrying value |
Amortized cost basis |
1 |
Allowance for credit losses |
Net carrying value |
|||||
CHF million | |||||||||||||
Cash and due from banks |
|
|
|
|
|
|
|||||||
Interest-bearing deposits with banks |
|
( |
|
|
4 |
|
|
||||||
Securities purchased under resale agreements and securities borrowing transactions |
|
2 |
|
|
|
|
|
||||||
Loans |
|
2,3 |
( |
|
|
4,5 |
( |
|
|||||
Brokerage receivables |
|
2 |
( |
|
|
4 |
( |
|
|||||
Other assets |
|
( |
|
|
( |
|
|||||||
Total |
|
( |
|
|
( |
|
|||||||
1
Net of unearned income/deferred expenses, as applicable.
|
|||||||||||||
2
Excludes accrued interest in the total amount of CHF
|
|||||||||||||
3
Includes endangered interest of CHF
|
|||||||||||||
4
Excludes accrued interest in the total amount of CHF
|
|||||||||||||
5
Includes endangered interest of CHF
|
6M22 | 6M21 | ||||||||||||
Consumer |
Corporate & institutional |
Total |
Consumer |
Corporate & institutional |
Total |
||||||||
CHF million | |||||||||||||
Balance at beginning of period |
|
|
|
|
|
|
|||||||
Current-period provision for expected credit losses |
|
|
|
|
( |
( |
|||||||
of which provisions for interest 1 |
|
|
|
|
|
|
|||||||
Gross write-offs |
( |
( |
( |
( |
( |
( |
|||||||
Recoveries |
|
|
|
|
|
|
|||||||
Net write-offs |
( |
( |
( |
( |
( |
( |
|||||||
Foreign currency translation impact and other adjustments, net |
|
|
|
|
|
|
|||||||
Balance at end of period |
|
|
|
|
|
|
|||||||
of which individually evaluated |
|
|
|
|
|
|
|||||||
of which collectively evaluated |
|
|
|
|
|
|
|||||||
1
Represents the current-period net provision for accrued interest on non-accrual loans and lease financing transactions which is recognized as a reversal of interest income.
|
6M22 | 6M21 | ||||||||||||
in |
Consumer |
Corporate & institutional |
Total |
Consumer |
Corporate & institutional |
Total |
|||||||
CHF million | |||||||||||||
Purchases 1 |
|
|
|
|
|
|
|||||||
Reclassifications from loans held-for-sale 2 |
|
|
|
|
|
|
|||||||
Reclassifications to loans held-for-sale 3 |
|
|
|
|
|
|
|||||||
Sales 3 |
|
|
|
|
|
|
|||||||
Reclassifications from loans held-for-sale and reclassifications to loans held-for-sale represent non-cash transactions.
|
|||||||||||||
1
Includes drawdowns under purchased loan commitments.
|
|||||||||||||
2
Includes loans previously reclassified to held-for-sale that were not sold and were reclassified back to loans held-to-maturity.
|
|||||||||||||
3
All loans held at amortized cost which are sold are reclassified to loans held-for-sale on or prior to the date of the sale.
|
6M22 | 6M21 | ||||
CHF million | |||||
Balance at beginning of period |
|
|
|||
Current-period provision for expected credit losses |
( |
|
|||
Gross write-offs |
( |
( |
|||
Recoveries |
|
|
|||
Net write-offs |
( |
( |
|||
Foreign currency translation impact and other adjustments, net |
|
( |
|||
Balance at end of period |
|
|
|||
of which individually evaluated |
|
|
|||
of which collectively evaluated |
|
|
6M22 | 2021 | ||||||||||||||||
Investment grade |
Non-investment grade |
Investment grade |
Non-investment grade |
||||||||||||||
end of | AAA to BBB | BB to C | D | Total | AAA to BBB | BB to C | D | Total | |||||||||
CHF million | |||||||||||||||||
Mortgages | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Loans collateralized by securities | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans 1 |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Consumer finance | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Consumer – total | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
1
Lombard loans are generally classified as revolving loans.
|
6M22 | 2021 | ||||||||||||||||
Investment grade |
Non-investment grade |
Investment grade |
Non-investment grade |
||||||||||||||
end of | AAA to BBB | BB to C | D | Total | AAA to BBB | BB to C | D | Total | |||||||||
CHF million | |||||||||||||||||
Real estate | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Commercial and industrial loans | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Financial institutions | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Governments and public institutions | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Corporate & institutional – total | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
6M22 | 2021 | ||||||||||||||||
Investment grade |
Non-investment grade |
Investment grade |
Non-investment grade |
||||||||||||||
end of | AAA to BBB | BB to C | D | Total | AAA to BBB | BB to C | D | Total | |||||||||
CHF million | |||||||||||||||||
Loans held at amortized cost – total | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term loans |
|
|
|
|
|
|
|
|
|||||||||
Revolving loans |
|
|
|
|
|
|
|
|
|||||||||
Total loans to third parties |
|
|
|
|
|
|
|
|
|||||||||
Total loans to entities under common control |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
1 |
|
|
|
|
1 | |||||||
1
Excludes accrued interest on loans held at amortized cost of CHF
|
6M22 | 2021 | ||||||||||||||||
Investment grade |
Non-investment grade |
Investment grade |
Non-investment grade |
||||||||||||||
end of | AAA to BBB | BB to C | D | Total | AAA to BBB | BB to C | D | Total | |||||||||
CHF million | |||||||||||||||||
Other financial assets held at amortized cost | |||||||||||||||||
2022 / 2021 |
|
|
|
|
|
|
|
|
|||||||||
2021 / 2020 |
|
|
|
|
|
|
|
|
|||||||||
2020 / 2019 |
|
|
|
|
|
|
|
|
|||||||||
2019 / 2018 |
|
|
|
|
|
|
|
|
|||||||||
2018 / 2017 |
|
|
|
|
|
|
|
|
|||||||||
Prior years |
|
|
|
|
|
|
|
|
|||||||||
Total term positions |
|
|
|
|
|
|
|
|
|||||||||
Revolving positions |
|
|
|
|
|
|
|
|
|||||||||
Total |
|
|
|
|
|
|
|
|
|||||||||
Includes primarily mortgage servicing advances and failed purchases.
|
Current | Past due | ||||||||||||||
end of |
|
Up to 30 days |
31–60 days |
61–90 days |
More than 90 days |
Total |
Total |
||||||||
6M22 (CHF million) | |||||||||||||||
Mortgages |
|
|
|
|
|
|
|
||||||||
Loans collateralized by securities |
|
|
|
|
|
|
|
||||||||
Consumer finance |
|
|
|
|
|
|
|
||||||||
Consumer |
|
|
|
|
|
|
|
||||||||
Real estate |
|
|
|
|
|
|
|
||||||||
Commercial and industrial loans |
|
|
|
|
|
|
|
||||||||
Financial institutions |
|
|
|
|
|
|
|
||||||||
Governments and public institutions |
|
|
|
|
|
|
|
||||||||
Corporate & institutional |
|
|
|
|
|
|
|
||||||||
Total loans to third parties |
|
|
|
|
|
|
|
||||||||
Total loans to entities under common control |
|
|
|
|
|
|
|
||||||||
Total loans held at amortized cost |
|
|
|
|
|
|
|
1 | |||||||
2021 (CHF million) | |||||||||||||||
Mortgages |
|
|
|
|
|
|
|
||||||||
Loans collateralized by securities |
|
|
|
|
|
|
|
||||||||
Consumer finance |
|
|
|
|
|
|
|
||||||||
Consumer |
|
|
|
|
|
|
|
||||||||
Real estate |
|
|
|
|
|
|
|
||||||||
Commercial and industrial loans |
|
|
|
|
|
|
|
||||||||
Financial institutions |
|
|
|
|
|
|
|
||||||||
Governments and public institutions |
|
|
|
|
|
|
|
||||||||
Corporate & institutional |
|
|
|
|
|
|
|
||||||||
Total loans to third parties |
|
|
|
|
|
|
|
||||||||
Total loans to entities under common control |
|
|
|
|
|
|
|
||||||||
Total loans held at amortized cost |
|
|
|
|
|
|
|
1 | |||||||
1
Excludes accrued interest on loans held at amortized cost of CHF
|
6M22 | 6M21 | ||||||||||||||||
Amortized cost of non-accrual assets at beginning of period |
Amortized cost of non-accrual assets at end of period |
Interest income recognized |
Amortized cost of non-accrual assets with no specific allowance at end of period |
Amortized cost of non-accrual assets at beginning of period |
Amortized cost of non-accrual assets at end of period |
Interest income recognized |
Amortized cost of non-accrual assets with no specific allowance at end of period |
||||||||||
CHF million | |||||||||||||||||
Mortgages |
|
|
|
|
|
|
|
|
|||||||||
Loans collateralized by securities |
|
|
|
|
|
|
|
|
|||||||||
Consumer finance |
|
|
|
|
|
|
|
|
|||||||||
Consumer |
|
|
|
|
|
|
|
|
|||||||||
Real estate |
|
|
|
|
|
|
|
|
|||||||||
Commercial and industrial loans |
|
|
|
|
|
|
|
|
|||||||||
Financial institutions |
|
|
|
|
|
|
|
|
|||||||||
Governments and public institutions |
|
|
|
|
|
|
|
|
|||||||||
Corporate & institutional |
|
|
|
|
|
|
|
|
|||||||||
Total loans held at amortized cost |
|
|
|
|
|
|
|
|
6M22 | 6M21 | ||||||||||||
in |
Number of contracts |
Recorded investment – pre- modification |
Recorded investment – post- modification |
Number of contracts |
Recorded investment – pre- modification |
Recorded investment – post- modification |
|||||||
CHF million, except where indicated | |||||||||||||
Real estate |
|
|
|
|
|
|
|||||||
Commercial and industrial loans |
|
|
|
|
|
|
|||||||
Financial institutions |
|
|
|
|
|
|
|||||||
Total loans |
|
|
|
|
|
|
6M22 | 6M21 | ||||||||
in |
Number of contracts |
Recorded investment |
Number of contracts |
Recorded investment |
|||||
CHF million, except where indicated | |||||||||
Loans collateralized by securities |
|
|
|
|
|||||
Total loans |
|
|
|
|
6M22 |
Wealth Management |
Investment Bank |
Swiss Bank |
Asset Management |
Bank |
1 | |||||
Gross amount of goodwill (CHF million) | |||||||||||
Balance at beginning of period |
|
|
|
|
|
||||||
Foreign currency translation impact |
|
|
|
|
|
||||||
Other |
( |
|
|
|
|
||||||
Balance at end of period |
|
|
|
|
|
||||||
Accumulated impairment (CHF million) | |||||||||||
Balance at beginning of period |
|
|
|
|
|
||||||
Impairment losses |
|
|
|
|
|
||||||
Balance at end of period |
|
|
|
|
|
||||||
Net book value (CHF million) | |||||||||||
Net book value |
|
|
|
|
|
||||||
1
Gross amount of goodwill and accumulated impairment include CHF
|
end of | 6M22 | 2021 | |||
Other assets (CHF million) | |||||
Cash collateral on derivative instruments |
|
|
|||
Cash collateral on non-derivative transactions |
|
|
|||
Derivative instruments used for hedging |
|
|
|||
Assets held-for-sale |
|
|
|||
of which loans 1 |
|
|
|||
allowance for loans held-for-sale |
( |
( |
|||
of which real estate 2 |
|
|
|||
of which long-lived assets |
|
|
|||
Premises, equipment and right-of-use assets |
|
|
|||
Assets held for separate accounts |
|
|
|||
Interest and fees receivable |
|
|
|||
Deferred tax assets |
|
|
|||
Prepaid expenses |
|
|
|||
of which cloud computing arrangement implementation costs |
|
|
|||
Failed purchases |
|
|
|||
Defined benefit pension and post-retirement plan assets |
|
|
|||
Other |
|
|
|||
of which digital asset safeguarding assets |
|
– | |||
Other assets |
|
|
|||
Other liabilities (CHF million) | |||||
Cash collateral on derivative instruments |
|
|
|||
Cash collateral on non-derivative transactions |
|
|
|||
Derivative instruments used for hedging |
|
|
|||
Operating leases liabilities |
|
|
|||
Provisions |
|
|
|||
of which expected credit losses on off-balance sheet credit exposures |
|
|
|||
Restructuring liabilities |
|
|
|||
Liabilities held for separate accounts |
|
|
|||
Interest and fees payable |
|
|
|||
Current tax liabilities |
|
|
|||
Deferred tax liabilities |
|
|
|||
Failed sales |
|
|
|||
Defined benefit pension and post-retirement plan liabilities |
|
|
|||
Other |
|
|
|||
of which digital asset safeguarding liabilities |
|
– | |||
Other liabilities |
|
|
|||
1
Included as of the end of 6M22 and 2021 were CHF
|
|||||
2
As of the end of 6M22 and 2021, real estate held-for-sale included foreclosed or repossessed real estate of CHF
|
end of | 6M22 | 2021 | |||
Long-term debt (CHF million) | |||||
Senior |
|
|
|||
Subordinated |
|
|
|||
Non-recourse liabilities from consolidated VIEs |
|
|
|||
Long-term debt |
|
|
|||
of which reported at fair value |
|
|
|||
of which structured notes |
|
|
end of | 6M22 | 2021 | |||
Structured notes by product (CHF million) | |||||
Equity |
|
|
|||
Fixed income |
|
|
|||
Credit |
|
|
|||
Other |
|
|
|||
Total structured notes |
|
|
Gains/ (losses) on cash flow hedges |
Cumulative translation adjustments |
Unrealized gains/ (losses) on securities |
1 |
Actuarial gains/ (losses) |
Net prior service credit/ (cost) |
Gains/ (losses) on liabilities relating to credit risk |
AOCI |
||||||||
6M22 (CHF million) | |||||||||||||||
Balance at beginning of period |
( |
( |
|
( |
( |
( |
( |
||||||||
Increase/(decrease) |
( |
|
( |
|
( |
|
|
||||||||
Reclassification adjustments, included in net income/(loss) |
( |
|
|
|
|
|
( |
||||||||
Total increase/(decrease) |
( |
|
( |
|
|
|
|
||||||||
Balance at end of period |
( |
( |
|
( |
( |
|
( |
||||||||
6M21 (CHF million) | |||||||||||||||
Balance at beginning of period |
|
( |
|
( |
( |
( |
( |
||||||||
Increase/(decrease) |
( |
|
|
( |
( |
( |
|
||||||||
Reclassification adjustments, included in net income/(loss) |
( |
|
|
|
|
|
|
||||||||
Total increase/(decrease) |
( |
|
|
( |
|
|
|
||||||||
Balance at end of period |
|
( |
|
( |
( |
( |
( |
||||||||
1
No impairments on available-for-sale debt securities were recognized in net income/(loss) in 6M22 and 6M21.
|
in | 6M22 | 6M21 | |||
Reclassification adjustments, included in net income/(loss) (CHF million) | |||||
Actuarial gains/(losses) | |||||
Amortization of recognized actuarial losses 1 |
|
( |
|||
Tax expense/(benefit) |
( |
|
|||
Net of tax |
|
|
|||
1
These components are included in the computation of total benefit costs. Refer to "Note 26 – Pension and other post-retirement benefits" for further information.
|
6M22 | 2021 | ||||||||
end of |
Derivative assets |
Derivative liabilities |
Derivative assets |
Derivative liabilities |
|||||
Gross derivatives subject to enforceable master netting agreements (CHF billion) | |||||||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
( |
|
|
|
|||||
Interest rate products |
|
|
|
|
|||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Foreign exchange products |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Equity/index-related products |
|
|
|
|
|||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Credit derivatives |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Other products 1 |
|
|
|
|
|||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Total gross derivatives subject to enforceable master netting agreements |
|
|
|
|
|||||
Offsetting (CHF billion) | |||||||||
OTC-cleared |
( |
( |
( |
( |
|||||
OTC |
( |
( |
( |
( |
|||||
Exchange-traded |
( |
( |
( |
( |
|||||
Offsetting |
( |
( |
( |
( |
|||||
of which counterparty netting |
( |
( |
( |
( |
|||||
of which cash collateral netting |
( |
( |
( |
( |
|||||
Net derivatives presented in the consolidated balance sheets (CHF billion) | |||||||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Total net derivatives subject to enforceable master netting agreements |
|
|
|
|
|||||
Total derivatives not subject to enforceable master netting agreements 2 |
|
|
|
|
|||||
Total net derivatives presented in the consolidated balance sheets |
|
|
|
|
|||||
of which recorded in trading assets and trading liabilities |
|
|
|
|
|||||
of which recorded in other assets and other liabilities |
|
|
|
|
|||||
1
Primarily precious metals, commodity and energy products.
|
|||||||||
2
Represents derivatives where a legal opinion supporting the enforceability of netting in the event of default or termination under the agreement is not in place.
|
6M22 | 2021 | ||||||||||||
end of |
Gross |
Offsetting |
Net book value |
Gross |
Offsetting |
Net book value |
|||||||
Securities purchased under resale agreements and securities borrowing transactions (CHF billion) | |||||||||||||
Securities purchased under resale agreements |
|
( |
|
|
( |
|
|||||||
Securities borrowing transactions |
|
|
|
|
|
|
|||||||
Total subject to enforceable master netting agreements |
|
( |
|
|
( |
|
|||||||
Total not subject to enforceable master netting agreements 1 |
|
– |
|
|
– |
|
|||||||
Total |
|
( |
|
2 |
|
( |
|
2 | |||||
1
Represents securities purchased under resale agreements and securities borrowing transactions where a legal opinion supporting the enforceability of netting in the event of default or termination under the agreement is not in place.
|
|||||||||||||
2
CHF
|
6M22 | 2021 | ||||||||||||
end of |
Gross |
Offsetting |
Net book value |
Gross |
Offsetting |
Net book value |
|||||||
Securities sold under repurchase agreements and securities lending transactions (CHF billion) | |||||||||||||
Securities sold under repurchase agreements |
|
( |
|
|
( |
|
|||||||
Securities lending transactions |
|
|
|
|
|
|
|||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
|
|||||||
Total subject to enforceable master netting agreements |
|
( |
|
|
( |
|
|||||||
Total not subject to enforceable master netting agreements 1 |
|
– |
|
|
– |
|
|||||||
Total |
|
( |
|
|
( |
|
|||||||
of which securities sold under repurchase agreements and securities lending transactions |
|
( |
|
2 |
|
( |
|
2 | |||||
of which obligation to return securities received as collateral, at fair value |
|
|
|
|
|
|
|||||||
1
Represents securities sold under repurchase agreements and securities lending transactions where a legal opinion supporting the enforceability of netting in the event of default or termination under the agreement is not in place.
|
|||||||||||||
2
CHF
|
6M22 | 2021 | ||||||||||||||||
end of |
Net |
Financial instruments |
1 |
Cash collateral received/ pledged |
1 |
Net exposure |
Net |
Financial instruments |
1 |
Cash collateral received/ pledged |
1 |
Net exposure |
|||||
Financial assets subject to enforceable master netting agreements (CHF billion) | |||||||||||||||||
Derivatives |
|
|
|
|
|
|
|
|
|||||||||
Securities purchased under resale agreements |
|
|
|
|
|
|
|
|
|||||||||
Securities borrowing transactions |
|
|
|
|
|
|
|
|
|||||||||
Total financial assets subject to enforceable master netting agreements |
|
|
|
|
|
|
|
|
|||||||||
Financial liabilities subject to enforceable master netting agreements (CHF billion) | |||||||||||||||||
Derivatives |
|
|
|
|
|
|
|
|
|||||||||
Securities sold under repurchase agreements |
|
|
|
|
|
|
|
|
|||||||||
Securities lending transactions |
|
|
|
|
|
|
|
|
|||||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
|
|
|
|||||||||
Total financial liabilities subject to enforceable master netting agreements |
|
|
|
|
|
|
|
|
|||||||||
1
The total amount reported in financial instruments (recognized financial assets and financial liabilities and non-cash financial collateral) and cash collateral is limited to the amount of the related instruments presented in the consolidated balance sheets and therefore any over-collateralization of these positions is not included.
|
in | 6M22 | 6M21 | |||
Effective tax rate (%) |
( |
|
in | 6M22 | ||
Income tax expense computed at the Swiss statutory tax rate of 18.5% (CHF million) |
( |
||
Increase/(decrease) in income taxes resulting from | |||
Foreign tax rate differential |
|
||
Changes in tax law and rates |
|
||
Other non-deductible expenses |
|
||
Changes in deferred tax valuation allowance |
|
||
Lower taxed income |
( |
||
(Windfall tax benefits)/shortfall tax charges on share-based compensation |
|
||
Other |
|
||
Income tax expense |
|
end of | 6M22 | 2021 | |||
Net deferred tax assets (CHF million) | |||||
Deferred tax assets |
|
|
|||
of which net operating losses |
|
|
|||
of which deductible temporary differences |
|
|
|||
Deferred tax liabilities |
( |
( |
|||
Net deferred tax assets |
|
|
in | 6M22 | 6M21 | |||
Deferred compensation expense (CHF million) | |||||
Share awards |
|
|
|||
Performance share awards |
|
|
|||
Contingent Capital Awards |
|
|
|||
Cash awards |
|
|
|||
Retention awards |
|
|
|||
Strategic Delivery Plan |
|
– | |||
Total deferred compensation expense |
|
|
end of | 6M22 | ||
Estimated unrecognized compensation expense (CHF million) | |||
Share awards |
|
||
Performance share awards |
|
||
Contingent Capital Awards |
|
||
Cash awards |
|
||
Retention awards |
|
||
Strategic Delivery Plan |
|
||
Total |
|
||
Aggregate remaining weighted-average requisite service period (years) | |||
Aggregate remaining weighted-average requisite service period |
|
6M22 | |||||||
Number of awards (in millions) |
Share awards |
Performance share awards |
Strategic Delivery Plan |
||||
Share-based award activities | |||||||
Balance at beginning of period |
|
|
|
||||
Granted |
|
|
|
||||
Settled |
( |
( |
|
||||
Forfeited |
( |
( |
( |
||||
Balance at end of period |
|
|
|
||||
of which vested |
|
|
|
||||
of which unvested |
|
|
|
in | 6M22 | 6M21 | |||
Net periodic benefit costs/(credits) (CHF million) | |||||
Service costs on benefit obligation |
|
|
|||
Interest costs on benefit obligation |
|
|
|||
Expected return on plan assets |
( |
( |
|||
Amortization of recognized prior service cost/(credit) |
|
|
|||
Amortization of recognized actuarial losses |
|
|
|||
Settlement losses/(gains) |
|
( |
|||
Net periodic benefit costs |
|
( |
|||
Service costs on benefit obligation are reflected in compensation and benefits. Other components of net periodic benefit costs are reflected in general and administrative expenses.
|
Trading | Hedging | 1 | |||||||||||
end of 6M22 |
Notional amount |
Positive replacement value (PRV) |
Negative replacement value (NRV) |
Notional amount |
Positive replacement value (PRV) |
Negative replacement value (NRV) |
|||||||
Derivative instruments (CHF billion) | |||||||||||||
Forwards and forward rate agreements |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Interest rate products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Foreign exchange products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Equity/index-related products |
|
|
|
|
|
|
|||||||
Credit derivatives 2 |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Other products 3 |
|
|
|
|
|
|
|||||||
Total derivative instruments |
|
|
|
|
|
|
|||||||
The notional amount, PRV and NRV (trading and hedging) was CHF
|
|||||||||||||
1
Relates to derivative contracts that qualify for hedge accounting under US GAAP.
|
|||||||||||||
2
Primarily credit default swaps.
|
|||||||||||||
3
Primarily precious metals, commodity and energy products.
|
Trading | Hedging | 1 | |||||||||||
end of 2021 |
Notional amount |
Positive replacement value (PRV) |
Negative replacement value (NRV) |
Notional amount |
Positive replacement value (PRV) |
Negative replacement value (NRV) |
|||||||
Derivative instruments (CHF billion) | |||||||||||||
Forwards and forward rate agreements |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Interest rate products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Foreign exchange products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Equity/index-related products |
|
|
|
|
|
|
|||||||
Credit derivatives 3 |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Other products 4 |
|
|
|
|
|
|
|||||||
Total derivative instruments |
|
|
|
|
|
|
|||||||
The notional amount, PRV and NRV (trading and hedging) was CHF
|
|||||||||||||
1
Relates to derivative contracts that qualify for hedge accounting under US GAAP.
|
|||||||||||||
2
Prior period has been revised.
|
|||||||||||||
3
Primarily credit default swaps.
|
|||||||||||||
4
Primarily precious metals, commodity and energy products.
|
in | 6M22 | 6M21 | |||
Interest rate products (CHF million) | |||||
Hedged items 1 |
|
|
|||
Derivatives designated as hedging instruments 1 |
( |
( |
|||
The accrued interest on fair value hedges is recorded in net interest income and is excluded from this table.
|
|||||
1
Included in net interest income.
|
6M22 | 2021 | ||||||||||||
Hedged items | Hedged items | ||||||||||||
end of |
Carrying amount |
Hedging adjustments |
1 |
Discontinued hedges |
2 |
Carrying amount |
Hedging adjustments |
1 |
Discontinued hedges |
2 | |||
Assets (CHF billion) | |||||||||||||
Investment securities |
|
( |
|
|
|
|
|||||||
Net loans |
|
( |
( |
|
( |
|
|||||||
Liabilities (CHF billion) | |||||||||||||
Long-term debt |
|
( |
( |
|
( |
|
|||||||
1
Relates to the cumulative amount of fair value hedging adjustments included in the carrying amount.
|
|||||||||||||
2
Relates to the cumulative amount of fair value hedging adjustments remaining for any hedged items for which hedge accounting has been discontinued.
|
in | 6M22 | 6M21 | |||
Interest rate products (CHF million) | |||||
Gains/(losses) recognized in AOCI on derivatives |
( |
( |
|||
Gains/(losses) reclassified from AOCI into interest and dividend income |
|
|
Foreign exchange products (CHF million) | |||||
Gains/(losses) recognized in AOCI on derivatives |
( |
|
|||
Total other operating expenses |
( |
|
|||
Gains/(losses) reclassified from AOCI into income |
( |
|
|||
1
Related to the forward points of a foreign currency forward.
|
in | 6M22 | 6M21 | |||
Foreign exchange products (CHF million) | |||||
Gains/(losses) recognized in the cumulative translation adjustments section of AOCI |
( |
( |
6M22 | 2021 | ||||||||||||||||
end of |
Bilateral counterparties |
Special purpose entities |
Accelerated terminations |
Total |
Bilateral counterparties |
Special purpose entities |
Accelerated terminations |
Total |
|||||||||
Contingent credit risk (CHF billion) | |||||||||||||||||
Current net exposure |
|
|
|
|
|
|
|
|
|||||||||
Collateral posted |
|
|
– |
|
|
|
– |
|
|||||||||
Impact of a one-notch downgrade event |
|
|
|
|
|
|
|
|
|||||||||
Impact of a two-notch downgrade event |
|
|
|
|
|
|
|
|
|||||||||
Impact of a three-notch downgrade event |
|
|
|
|
|
|
|
|
|||||||||
The impact of a downgrade event reflects the amount of additional collateral required for bilateral counterparties and special purpose entities and the amount of additional termination expenses for accelerated terminations, respectively.
|
6M22 | 2021 | ||||||||||||||||||||
end of |
Credit protection sold |
Credit protection purchased |
1 |
Net credit protection (sold)/ purchased |
Other protection purchased |
Fair value of credit protection sold |
Credit protection sold |
Credit protection purchased |
1 |
Net credit protection (sold)/ purchased |
Other protection purchased |
Fair value of credit protection sold |
|||||||||
Single-name instruments (CHF billion) | |||||||||||||||||||||
Investment grade 2 |
( |
|
( |
|
|
( |
|
( |
|
|
|||||||||||
Non-investment grade |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Total single-name instruments |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which sovereign |
( |
|
( |
|
( |
( |
|
( |
|
( |
|||||||||||
of which non-sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Multi-name instruments (CHF billion) | |||||||||||||||||||||
Investment grade 2 |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Non-investment grade |
( |
|
( |
|
3 |
( |
( |
|
( |
|
3 |
( |
|||||||||
Total multi-name instruments |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which non-sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Total instruments (CHF billion) | |||||||||||||||||||||
Investment grade 2 |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Non-investment grade |
( |
|
( |
|
( |
( |
|
( |
|
( |
|||||||||||
Total instruments |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which sovereign |
( |
|
( |
|
( |
( |
|
( |
|
( |
|||||||||||
of which non-sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
1
Represents credit protection purchased with identical underlyings and recoveries.
|
|||||||||||||||||||||
2
Based on internal ratings of BBB and above.
|
|||||||||||||||||||||
3
Includes synthetic securitized loan portfolios.
|
end of | 6M22 | 2021 | |||
Credit derivatives (CHF billion) | |||||
Credit protection sold |
|
|
|||
Credit protection purchased |
|
|
|||
Other protection purchased |
|
|
|||
Other instruments 1 |
|
|
|||
Total credit derivatives |
|
|
|||
1
Consists of total return swaps and other derivative instruments.
|
end of |
Maturity less than 1 year |
Maturity between 1 to 5 years |
Maturity greater than 5 years |
Total |
|||||
6M22 (CHF billion) | |||||||||
Single-name instruments |
|
|
|
|
|||||
Multi-name instruments |
|
|
|
|
|||||
Total instruments |
|
|
|
|
|||||
2021 (CHF billion) | |||||||||
Single-name instruments |
|
|
|
|
|||||
Multi-name instruments |
|
|
|
|
|||||
Total instruments |
|
|
|
|
end of |
Maturity less than 1 year |
Maturity greater than 1 year |
Total gross amount |
Total net amount |
1 |
Carrying value |
Collateral received |
||||||
6M22 (CHF million) | |||||||||||||
Credit guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Performance guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Derivatives 2 |
|
|
|
|
|
– | 3 | ||||||
Other guarantees |
|
|
|
|
|
|
|||||||
Total guarantees |
|
|
|
|
|
|
|||||||
2021 (CHF million) | |||||||||||||
Credit guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Performance guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Derivatives 2 |
|
|
|
|
|
– | 3 | ||||||
Other guarantees |
|
|
|
|
|
|
|||||||
Total guarantees |
|
|
|
|
|
|
|||||||
1
Total net amount is computed as the gross amount less any participations.
|
|||||||||||||
2
Excludes derivative contracts with certain active commercial and investment banks and certain other counterparties, as such contracts can be cash settled and the Bank had no basis to conclude it was probable that the counterparties held, at inception, the underlying instruments.
|
|||||||||||||
3
Collateral for derivatives accounted for as guarantees is not considered significant.
|
6M22 | 2021 | ||||||||||||||||||||
end of |
Maturity less than 1 year |
Maturity greater than 1 year |
Total gross amount |
Total net amount |
1 |
Collateral received |
Maturity less than 1 year |
Maturity greater than 1 year |
Total gross amount |
Total net amount |
1 |
Collateral received |
|||||||||
Other commitments (CHF million) | |||||||||||||||||||||
Irrevocable commitments under documentary credits |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Irrevocable loan commitments |
|
|
|
2 |
|
|
|
|
|
2 |
|
|
|||||||||
Forward reverse repurchase agreements |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other commitments |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other commitments |
|
|
|
|
|
|
|
|
|
|
|||||||||||
1
Total net amount is computed as the gross amount less any participations.
|
|||||||||||||||||||||
2
Irrevocable loan commitments do not include a total gross amount of CHF
|
in | 6M22 | 6M21 | |||
Gains/(losses) and cash flows (CHF million) | |||||
CMBS | |||||
Net gain 1 |
|
|
|||
Proceeds from transfer of assets |
|
|
|||
Cash received on interests that continue to be held |
|
|
|||
RMBS | |||||
Net gain/(loss) 1 |
( |
|
|||
Proceeds from transfer of assets |
|
|
|||
Purchases of previously transferred financial assets or its underlying collateral |
|
( |
|||
Servicing fees |
|
|
|||
Cash received on interests that continue to be held |
|
|
|||
Other asset-backed financings | |||||
Net gain 1 |
|
|
|||
Proceeds from transfer of assets |
|
|
|||
Purchases of previously transferred financial assets or its underlying collateral |
( |
( |
|||
Fees 2 |
|
|
|||
Cash received on interests that continue to be held |
|
|
|||
1
Includes underwriting revenues, deferred origination fees, gains or losses on the sale of collateral to the SPE and gains or losses on the sale of newly issued securities to third parties, but excludes net interest income on assets prior to the securitization. The gains or losses on the sale of the collateral is the difference between the fair value on the day prior to the securitization pricing date and the sale price of the loans.
|
|||||
2
Represents management fees and performance fees earned for investment management services provided to managed CLOs.
|
end of | 6M22 | 2021 | |||
CHF million | |||||
CMBS | |||||
Principal amount outstanding |
|
|
|||
Total assets of SPE |
|
|
|||
RMBS | |||||
Principal amount outstanding |
|
|
|||
Total assets of SPE |
|
|
|||
Other asset-backed financings | |||||
Principal amount outstanding |
|
|
|||
Total assets of SPE |
|
|
|||
Principal amount outstanding relates to assets transferred from the Bank and does not include principal amounts for assets transferred from third parties.
|
6M22 | 6M21 | ||||||||||||||||
at time of transfer, in | CMBS | RMBS | CMBS | RMBS | |||||||||||||
CHF million, except where indicated | |||||||||||||||||
Fair value of beneficial interests |
|
|
|
|
|||||||||||||
of which level 2 |
|
|
|
|
|||||||||||||
of which level 3 |
|
|
|
|
|||||||||||||
Weighted-average life, in years |
|
|
|
|
|||||||||||||
Prepayment speed assumption (rate per annum), in % 1 | – | 2 |
|
– |
|
– | 2 |
|
– |
|
|||||||
Cash flow discount rate (rate per annum), in % 3 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||
Expected credit losses (rate per annum), in % 4 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||
Transfers of assets in which the Bank does not have beneficial interests are not included in this table.
|
|||||||||||||||||
1
Prepayment speed assumption (PSA) is an industry standard prepayment speed metric used for projecting prepayments over the life of a residential mortgage loan. PSA utilizes the constant prepayment rate (CPR) assumptions. A
|
|||||||||||||||||
2
To deter prepayment, commercial mortgage loans typically have prepayment protection in the form of prepayment lockouts and yield maintenances.
|
|||||||||||||||||
3
The rate was based on the weighted-average yield on the beneficial interests.
|
|||||||||||||||||
4
The range of expected credit losses only reflects instruments with an expected credit loss greater than zero unless all of the instruments have an expected credit loss of zero.
|
6M22 | 2021 | ||||||||||||||||||||||||
end of |
CMBS |
1 |
RMBS |
Other asset- backed financing activities |
2 |
CMBS |
1 |
RMBS |
Other asset- backed financing activities |
2 | |||||||||||||||
CHF million, except where indicated | |||||||||||||||||||||||||
Fair value of beneficial interests |
|
|
|
|
|
|
|||||||||||||||||||
of which non-investment grade |
|
|
|
|
|
|
|||||||||||||||||||
Weighted-average life, in years |
|
|
|
|
|
|
|||||||||||||||||||
Prepayment speed assumption (rate per annum), in % 3 | – |
|
– |
|
– | – |
|
– |
|
– | |||||||||||||||
Impact on fair value from 10% adverse change | – |
( |
– | – |
( |
– | |||||||||||||||||||
Impact on fair value from 20% adverse change | – |
( |
– | – |
( |
– | |||||||||||||||||||
Cash flow discount rate (rate per annum), in % 4 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||||
Impact on fair value from 10% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
Impact on fair value from 20% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
Expected credit losses (rate per annum), in % 5 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||||
Impact on fair value from 10% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
Impact on fair value from 20% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
1
To deter prepayment, commercial mortgage loans typically have prepayment protection in the form of prepayment lockouts and yield maintenances.
|
|||||||||||||||||||||||||
2
CDOs within this category are generally structured to be protected from prepayment risk.
|
|||||||||||||||||||||||||
3
PSA is an industry standard prepayment speed metric used for projecting prepayments over the life of a residential mortgage loan. PSA utilizes the CPR assumptions. A
|
|||||||||||||||||||||||||
4
The rate was based on the weighted-average yield on the beneficial interests.
|
|||||||||||||||||||||||||
5
The range of expected credit losses only reflects instruments with an expected credit loss greater than zero unless all of the instruments have an expected credit loss of zero.
|
end of | 6M22 | 2021 | |||
CHF million | |||||
RMBS | |||||
Other assets |
|
|
|||
Liability to SPE, included in other liabilities |
|
( |
|||
Other asset-backed financings | |||||
Trading assets |
|
|
|||
Other assets |
|
|
|||
Liability to SPE, included in other liabilities |
( |
( |
end of | 6M22 | 2021 | |||
CHF billion | |||||
Government debt securities |
|
|
|||
Corporate debt securities |
|
|
|||
Asset-backed securities |
|
|
|||
Equity securities |
|
|
|||
Other |
|
|
|||
Securities sold under repurchase agreements |
|
|
|||
Government debt securities |
|
|
|||
Corporate debt securities |
|
|
|||
Asset-backed securities |
|
|
|||
Equity securities |
|
|
|||
Other |
|
|
|||
Securities lending transactions |
|
|
|||
Government debt securities |
|
|
|||
Corporate debt securities |
|
|
|||
Asset-backed securities |
|
|
|||
Equity securities |
|
|
|||
Other |
|
|
|||
Obligation to return securities received as collateral, at fair value |
|
|
|||
Total |
|
|
Remaining contractual maturities | |||||||||||
end of |
No stated maturity |
1 |
Up to 30 days |
2 |
31-90 days |
More than 90 days |
Total |
||||
6M22 (CHF billion) | |||||||||||
Securities sold under repurchase agreements |
|
|
|
|
|
||||||
Securities lending transactions |
|
|
|
|
|
||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
||||||
Total |
|
|
|
|
|
||||||
2021 (CHF billion) | |||||||||||
Securities sold under repurchase agreements |
|
|
|
|
|
||||||
Securities lending transactions |
|
|
|
|
|
||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
||||||
Total |
|
|
|
|
|
||||||
1
Includes contracts with no contractual maturity that may contain termination arrangements subject to a notice period.
|
|||||||||||
2
Includes overnight transactions.
|
Financial intermediation | |||||||||||||||
end of |
CDO/ CLO |
CP Conduit |
Securi- tizations |
Funds |
Loans |
Other |
Total |
||||||||
6M22 (CHF million) | |||||||||||||||
Cash and due from banks |
|
|
|
|
|
|
|
||||||||
Trading assets |
|
|
|
|
|
|
|
||||||||
Other investments |
|
|
|
|
|
|
|
||||||||
Net loans |
|
|
|
|
|
|
|
||||||||
Other assets |
|
|
|
|
|
|
|
||||||||
of which loans held-for-sale |
|
|
|
|
|
|
|
||||||||
of which premises and equipment |
|
|
|
|
|
|
|
||||||||
Total assets of consolidated VIEs |
|
|
|
|
|
|
|
||||||||
Trading liabilities |
|
|
|
|
|
|
|
||||||||
Short-term borrowings |
|
|
|
|
|
|
|
||||||||
Long-term debt |
|
|
|
|
|
|
|
||||||||
Other liabilities |
|
|
|
|
|
|
|
||||||||
Total liabilities of consolidated VIEs |
|
|
|
|
|
|
|
||||||||
2021 (CHF million) | |||||||||||||||
Cash and due from banks |
|
|
|
|
|
|
|
||||||||
Trading assets |
|
|
|
|
|
|
|
||||||||
Other investments |
|
|
|
|
|
|
|
||||||||
Net loans |
|
|
|
|
|
|
|
||||||||
Other assets |
|
|
|
|
|
|
|
||||||||
of which loans held-for-sale |
|
|
|
|
|
|
|
||||||||
of which premises and equipment |
|
|
|
|
|
|
|
||||||||
Total assets of consolidated VIEs |
|
|
|
|
|
|
|
||||||||
Trading liabilities |
|
|
|
|
|
|
|
||||||||
Short-term borrowings |
|
|
|
|
|
|
|
||||||||
Long-term debt |
|
|
|
|
|
|
|
||||||||
Other liabilities |
|
|
|
|
|
|
|
||||||||
Total liabilities of consolidated VIEs |
|
|
|
|
|
|
|
Financial intermediation | |||||||||||||||
end of |
CDO/ CLO |
CP Conduit |
1 |
Securi- tizations |
Funds |
Loans |
Other |
Total |
|||||||
6M22 (CHF million) | |||||||||||||||
Trading assets |
|
|
|
|
|
|
|
||||||||
Net loans |
|
|
|
|
|
|
|
||||||||
Other assets |
|
|
|
|
|
|
|
||||||||
Total variable interest assets |
|
|
|
|
|
|
|
||||||||
Maximum exposure to loss |
|
|
|
|
|
|
|
||||||||
Total assets of non-consolidated VIEs |
|
|
|
|
|
|
|
||||||||
2021 (CHF million) | |||||||||||||||
Trading assets |
|
|
|
|
|
|
|
||||||||
Net loans |
|
|
|
|
|
|
|
||||||||
Other assets |
|
|
|
|
|
|
|
||||||||
Total variable interest assets |
|
|
|
|
|
|
|
||||||||
Maximum exposure to loss |
|
|
|
|
|
|
|
||||||||
Total assets of non-consolidated VIEs |
|
|
|
|
|
|
|
||||||||
1
Includes liquidity facilities provided to third-party CP conduits through Alpine.
|
end of 6M22 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Assets measured at net asset value per share |
2 |
Total |
|||||
Assets (CHF million) | |||||||||||||
Cash and due from banks |
|
|
|
– | – |
|
|||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
– | – |
|
|||||||
Securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading assets |
|
|
|
( |
|
|
|||||||
of which debt securities |
|
|
|
– |
|
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which corporates |
|
|
|
– |
|
|
|||||||
of which RMBS |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
of which other derivatives |
|
|
|
– | – | – | |||||||
of which other trading assets |
|
|
|
– | – |
|
|||||||
Investment securities |
|
|
|
– | – |
|
|||||||
Other investments |
|
|
|
– |
|
|
|||||||
of which other equity investments |
|
|
|
– |
|
|
|||||||
of which life finance instruments |
|
|
|
– | – |
|
|||||||
Loans |
|
|
|
– | – |
|
|||||||
of which commercial and industrial loans |
|
|
|
– | – |
|
|||||||
of which financial institutions |
|
|
|
– | – |
|
|||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
– | – |
|
|||||||
Other assets |
|
|
|
( |
– |
|
|||||||
of which failed purchases |
|
|
|
– | – |
|
|||||||
of which loans held-for-sale |
|
|
|
– | – |
|
|||||||
Total assets at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
end of 6M22 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Liabilities measured at net asset value per share |
2 |
Total |
|||||
Liabilities (CHF million) | |||||||||||||
Due to banks |
|
|
|
– | – |
|
|||||||
Customer deposits |
|
|
|
– | – |
|
|||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
– | – |
|
|||||||
Obligation to return securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading liabilities |
|
|
|
( |
|
|
|||||||
of which short positions |
|
|
|
– |
|
|
|||||||
of which debt securities |
|
|
|
– | – |
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which corporates |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
of which other derivatives | 11 | 213 | 560 | – | – | 296 | |||||||
Short-term borrowings |
|
|
|
– | – |
|
|||||||
Long-term debt |
|
|
|
– | – |
|
|||||||
of which structured notes over one year and up to two years |
|
|
|
– | – |
|
|||||||
of which structured notes over two years |
|
|
|
– | – |
|
|||||||
of which other debt instruments over two years |
|
|
|
– | – |
|
|||||||
of which high-trigger instruments |
|
|
|
– | – |
|
|||||||
Other liabilities |
|
|
|
( |
– |
|
|||||||
Total liabilities at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
end of 2021 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Assets measured at net asset value per share |
2 |
Total |
|||||
Assets (CHF million) | |||||||||||||
Cash and due from banks |
|
|
|
– | – |
|
|||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
– | – |
|
|||||||
Securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading assets |
|
|
|
( |
|
|
|||||||
of which debt securities |
|
|
|
– |
|
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which corporates |
|
|
|
– |
|
|
|||||||
of which RMBS |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
of which other derivatives |
|
|
|
– | – | – | |||||||
of which other trading assets |
|
|
|
– | – |
|
|||||||
Investment securities |
|
|
|
– | – |
|
|||||||
Other investments |
|
|
|
– |
|
|
|||||||
of which other equity investments |
|
|
|
– |
|
|
|||||||
of which life finance instruments |
|
|
|
– | – |
|
|||||||
Loans |
|
|
|
– | – |
|
|||||||
of which commercial and industrial loans |
|
|
|
– | – |
|
|||||||
of which financial institutions |
|
|
|
– | – |
|
|||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
– | – |
|
|||||||
Other assets |
|
|
|
( |
– |
|
|||||||
of which failed purchases |
|
|
|
– | – |
|
|||||||
of which loans held-for-sale |
|
|
|
– | – |
|
|||||||
Total assets at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
end of 2021 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Liabilities measured at net asset value per share |
2 |
Total |
|||||
Liabilities (CHF million) | |||||||||||||
Due to banks |
|
|
|
– | – |
|
|||||||
Customer deposits |
|
|
|
– | – |
|
|||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
– | – |
|
|||||||
Obligation to return securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading liabilities |
|
|
|
( |
|
|
|||||||
of which short positions |
|
|
|
– |
|
|
|||||||
of which debt securities |
|
|
|
– | – |
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which corporates |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
Short-term borrowings |
|
|
|
– | – |
|
|||||||
Long-term debt |
|
|
|
– | – |
|
|||||||
of which structured notes over one year and up to two years |
|
|
|
– | – |
|
|||||||
of which structured notes over two years |
|
|
|
– | – |
|
|||||||
of which other debt instruments over two years |
|
|
|
– | – |
|
|||||||
of which high-trigger instruments |
|
|
|
– | – |
|
|||||||
of which other subordinated bonds |
|
|
|
– | – |
|
|||||||
Other liabilities |
|
|
|
( |
– |
|
|||||||
Total liabilities at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
Trading revenues |
Other revenues |
Accumulated other comprehensive income |
|||||||||||||||||||||||||||||||
6M22 |
Balance at beginning of period |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
Settlements |
On transfers out |
On all other |
On transfers out |
On all other |
On transfers out |
On all other |
Foreign currency translation impact |
Balance at end of period |
Changes in unrealized gains/losses |
1 | ||||||||||||||||
Assets (CHF million) | |||||||||||||||||||||||||||||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Trading assets |
|
|
( |
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|||||||||||||||||
of which debt securities |
|
|
( |
|
( |
|
|
( |
( |
|
( |
|
|
|
|
|
|||||||||||||||||
of which corporates |
|
|
( |
|
( |
|
|
( |
( |
|
|
|
|
|
|
|
|||||||||||||||||
of which RMBS |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which derivatives |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
of which interest rate products |
|
|
( |
|
|
|
( |
( |
|
|
|
|
|
|
|
|
|||||||||||||||||
of which other derivatives |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which other trading assets |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|||||||||||||||||
Other investments |
|
|
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
( |
|||||||||||||||||
of which other equity investments |
|
|
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
( |
|||||||||||||||||
of which life finance instruments |
|
|
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
Loans |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which commercial and industrial loans |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which financial institutions |
|
|
|
|
|
|
( |
|
|
|
|
|
|
|
|
( |
|||||||||||||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
|
|
|
|
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
Other assets |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which loans held-for-sale |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total assets at fair value |
|
|
( |
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|||||||||||||||||
Liabilities (CHF million) | |||||||||||||||||||||||||||||||||
Customer deposits |
|
|
|
|
|
|
( |
|
( |
|
|
|
( |
( |
|
( |
|||||||||||||||||
Obligation to return securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Trading liabilities |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which derivatives |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which equity/index-related derivatives |
|
|
( |
|
|
|
( |
( |
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which other derivatives | 540 | 7 | (4) | 0 | (61) | 89 | (113) | 3 | 73 | 0 | 0 | 0 | 0 | 26 | 560 | (15) | |||||||||||||||||
Short-term borrowings |
|
|
( |
|
|
|
( |
( |
( |
|
|
|
|
|
|
|
|||||||||||||||||
Long-term debt |
|
|
( |
|
|
|
( |
( |
( |
|
|
( |
( |
|
|
( |
|||||||||||||||||
of which structured notes over two years |
|
|
( |
|
|
|
( |
( |
( |
|
|
( |
( |
|
|
( |
|||||||||||||||||
of which other debt instruments over two years |
|
|
|
|
|
|
( |
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
Other liabilities |
|
|
( |
|
( |
|
( |
( |
( |
|
( |
|
|
|
|
|
|||||||||||||||||
Total liabilities at fair value |
|
|
( |
|
( |
|
( |
( |
( |
|
( |
( |
( |
|
|
( |
|||||||||||||||||
Net assets/(liabilities) at fair value |
( |
( |
|
|
( |
( |
|
|
|
( |
( |
|
|
( |
( |
|
|||||||||||||||||
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in unrealized (gains)/losses on total liabilities at fair value relating to assets and liabilities held at period end are included in net revenues or accumulated other comprehensive income. As of 6M22, changes in net unrealized gains/(losses) of CHF
|
Trading revenues |
Other revenues |
Accumulated other comprehensive income |
|||||||||||||||||||||||||||||||
6M21 |
Balance at beginning of period |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
Settlements |
On transfers out |
On all other |
On transfers out |
On all other |
On transfers out |
On all other |
Foreign currency translation impact |
Balance at end of period |
Changes in unrealized gains/losses |
1 | ||||||||||||||||
Assets (CHF million) | |||||||||||||||||||||||||||||||||
Securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Trading assets |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which debt securities |
|
|
( |
|
( |
|
|
( |
|
|
|
|
|
|
|
|
|||||||||||||||||
of which corporates |
|
|
( |
|
( |
|
|
( |
|
|
|
|
|
|
|
|
|||||||||||||||||
of which derivatives |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
of which interest rate products |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which other derivatives |
|
|
|
|
|
|
( |
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which other trading assets |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|||||||||||||||||
Other investments |
|
|
( |
|
( |
|
|
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
of which other equity investments |
|
|
( |
|
( |
|
|
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
of which life finance instruments |
|
|
|
|
( |
|
|
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
Loans |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which commercial and industrial loans |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which financial institutions |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
|
|
|
|
|
|
|
( |
|
|
|
|
( |
|||||||||||||||||
Other assets |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which loans held-for-sale |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|||||||||||||||||
Total assets at fair value |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Liabilities (CHF million) | |||||||||||||||||||||||||||||||||
Customer deposits |
|
|
|
|
|
|
|
|
( |
|
|
|
( |
|
|
|
|||||||||||||||||
Obligation to return securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Trading liabilities |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which derivatives |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which equity/index-related derivatives |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Short-term borrowings |
|
|
( |
|
|
|
( |
( |
|
|
|
|
|
|
|
|
|||||||||||||||||
Long-term debt |
|
|
( |
|
|
|
( |
|
( |
|
|
( |
( |
|
|
|
|||||||||||||||||
of which structured notes over one year and up to two years |
|
|
( |
|
|
|
( |
|
|
|
|
|
( |
|
|
|
|||||||||||||||||
of which structured notes over two years |
|
|
( |
|
|
|
( |
|
( |
|
|
( |
( |
|
|
( |
|||||||||||||||||
Other liabilities |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
Total liabilities at fair value |
|
|
( |
|
( |
|
( |
|
|
|
|
( |
( |
|
|
|
|||||||||||||||||
Net assets/(liabilities) at fair value |
|
( |
|
|
( |
( |
|
( |
( |
( |
|
|
|
( |
( |
( |
|||||||||||||||||
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in unrealized (gains)/losses on total liabilities at fair value relating to assets and liabilities held at period end are included in net revenues or accumulated other comprehensive income. As of 6M21, changes in net unrealized gains/(losses) of CHF (
|
6M22 | 2021 | ||||||||||||
end of |
Aggregate fair value |
Aggregate unpaid principal |
Difference |
Aggregate fair value |
Aggregate unpaid principal |
Difference |
|||||||
Financial instruments (CHF million) | |||||||||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
|
|
|
|||||||
Loans |
|
|
( |
|
|
( |
|||||||
Other assets 1 |
|
|
( |
|
|
( |
|||||||
Due to banks and customer deposits |
( |
( |
|
( |
( |
( |
|||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
( |
( |
|
( |
( |
( |
|||||||
Short-term borrowings |
( |
( |
|
( |
( |
|
|||||||
Long-term debt 2 |
( |
( |
|
( |
( |
|
|||||||
Other liabilities |
( |
( |
|
( |
( |
|
|||||||
Non-performing and non-interest-earning loans 3 |
|
|
( |
|
|
( |
|||||||
1
Primarily loans held-for-sale.
|
|||||||||||||
2
Long-term debt includes both principal-protected and non-principal protected instruments. For non-principal-protected instruments, the original notional amount has been reported in the aggregate unpaid principal.
|
|||||||||||||
3
Included in loans or other assets.
|
6M22 | 6M21 | ||||
in |
Net gains/ (losses) |
Net gains/ (losses) |
|||
Financial instruments (CHF million) | |||||
Interest-bearing deposits with banks |
|
1 |
|
1 | |
of which related to credit risk |
( |
|
|||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
1 |
|
1 | |
Other investments |
( |
2 |
|
3 | |
Loans |
( |
1 |
|
1 | |
of which related to credit risk |
( |
|
|||
Other assets |
|
1 |
|
1 | |
of which related to credit risk |
( |
|
|||
Due to banks and customer deposits |
( |
2 |
( |
2 | |
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
( |
1 |
( |
1 | |
Short-term borrowings |
|
2 |
( |
2 | |
of which related to credit risk |
|
( |
|||
Long-term debt |
|
2 |
( |
2 | |
Other liabilities |
( |
2 |
|
3 | |
of which related to credit risk |
( |
|
|||
1
Primarily recognized in net interest income.
|
|||||
2
Primarily recognized in trading revenues.
|
|||||
3
Primarily recognized in other revenues.
|
Gains/(losses) recorded into AOCI |
1 |
Gains/(losses) recorded in AOCI transferred to net income |
1 | ||||||||
in | 6M22 | Cumulative | 6M21 | 6M22 | 6M21 | ||||||
Financial instruments (CHF million) | |||||||||||
Customer deposits |
|
( |
|
|
|
||||||
Short-term borrowings |
|
( |
|
|
|
||||||
Long-term debt |
|
|
( |
|
|
||||||
of which treasury debt over two years |
|
|
( |
|
|
||||||
of which structured notes over two years |
|
|
|
|
|
||||||
Total |
|
|
|
|
|
||||||
1
Amounts are reflected gross of tax.
|
Carrying value |
Fair value |
||||||||||
end of | Level 1 | Level 2 | Level 3 | Total | |||||||
6M22 (CHF million) | |||||||||||
Financial assets | |||||||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
|
|
||||||
Loans |
|
|
|
|
|
||||||
Other financial assets 1 |
|
|
|
|
|
||||||
Financial liabilities | |||||||||||
Due to banks and customer deposits |
|
|
|
|
|
||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
|
|
||||||
Short-term borrowings |
|
|
|
|
|
||||||
Long-term debt |
|
|
|
|
|
||||||
Other financial liabilities 2 |
|
|
|
|
|
||||||
2021 (CHF million) | |||||||||||
Financial assets | |||||||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
|
|
||||||
Loans |
|
|
|
|
|
||||||
Other financial assets 1 |
|
|
|
|
|
||||||
Financial liabilities | |||||||||||
Due to banks and customer deposits |
|
|
|
|
|
||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
|
|
||||||
Short-term borrowings |
|
|
|
|
|
||||||
Long-term debt |
|
|
|
|
|
||||||
Other financial liabilities 2 |
|
|
|
|
|
||||||
1
Primarily includes cash and due from banks, interest-bearing deposits with banks, loans held-for-sale, cash collateral on derivative instruments, interest and fee receivables and non-marketable equity securities.
|
|||||||||||
2
Primarily includes cash collateral on derivative instruments and interest and fee payables.
|
end of | 6M22 | 2021 | |||
CHF million | |||||
Total assets pledged or assigned as collateral |
|
|
|||
of which encumbered |
|
|
end of | 6M22 | 2021 | |||
CHF million | |||||
Fair value of collateral received with the right to sell or repledge |
|
|
|||
of which sold or repledged |
|
|